Please assess the completion status of the following clinical trial:

Trial Title: NSAIDs vs Opioids for Post-op Pain in Supracondylar Humerus Fractures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* isolated supracondylar humerus fracture~* undergoing closed reduction with percutaneous pinning (CRPP)~Exclusion Criteria:~* Allergies to acetaminophen, ibuprofen, and/or acetaminophen-HYDROcodone~* Liver or renal disease~* history of bleeding disorder~* medical diagnosis of juvenile arthritis~* on chronic NSAIDs or Opioids PRIOR to the procedure~* medical diagnosis of coagulopathies, open fractures, other injuries at time of diagnosis (multi-system trauma)~* vascular compromise and/or compartment syndrome upon admission

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 13 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: OTHER): Standard of care- weight based dose of liquid acetaminophen-hydrocodone- 0.15 mg/kg/dose every six hours with a max dose of 10 mg/dose
- Treatment (Type: EXPERIMENTAL): Weight based dose of liquid acetaminophen and ibuprofen- acetaminophen 15 mg/kg/dose and ibuprofen 10 mg/kg/dose every six hours with a max dose of 650 mg/dose of acetaminophen and 600 mg/dose of ibuprofen.

Based on this trial design, predict the completion outcome and termination type (if applicable).